blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2493310

EP2493310 - BENZIMIDAZOLES AS FATTY ACID SYNTHASE INHIBITORS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  24.04.2015
Database last updated on 24.08.2024
Most recent event   Tooltip24.04.2015Application deemed to be withdrawnpublished on 27.05.2015  [2015/22]
Applicant(s)For all designated states
GlaxoSmithKline LLC
One Franklin Plaza
200 North 16th Street
Philadelphia, PA 19102 / US
[N/P]
Former [2012/36]For all designated states
GlaxoSmithKline LLC
One Franklin Plaza 200 North 16th Street
Philadelphia, PA 19102 / US
Inventor(s)01 / HALLMAN, Jason
Five Moore Drive
Cary NC 27513 / US
02 / LAUDEMAN, Christopher
Five Moore Drive
Durham NC 27712 / US
03 / LIU, Ronggang
Five Moore Drive
Berwyn PA 19312 / US
04 / MILLER, Aaron
Five Moore Drive
Research Triangle Park NC 27709 / US
05 / MOORE, Michael, Lee
1250 South Collegeville Road
Collegeville PA 19426 / US
06 / DOCK, Steven
Five Moore Drive
Research Triangle Park NC 27709 / US
07 / MUSSO, David
Five Moore Drive
Raleigh NC 27615 / US
08 / PARRISH, Cynthia
1250 South Collegeville Road
Collegeville PA 19426 / US
 [2012/36]
Representative(s)Reed, Michael Antony
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[N/P]
Former [2012/36]Reed, Michael Antony
GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road
Brentford, Middlesex TW8 9GS / GB
Application number, filing date10828881.227.10.2010
WO2010US54230
Priority number, dateUS20090256096P29.10.2009         Original published format: US 256096 P
US20090255230P27.10.2009         Original published format: US 255230 P
[2012/36]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011056635
Date:12.05.2011
Language:EN
[2011/19]
Type: A1 Application with search report 
No.:EP2493310
Date:05.09.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 12.05.2011 takes the place of the publication of the European patent application.
[2012/36]
Search report(s)International search report - published on:US12.05.2011
(Supplementary) European search report - dispatched on:EP07.02.2014
ClassificationIPC:A01N43/50, A61K31/415, C07D403/06, C07D403/14, C07D405/14, C07D413/14, C07D417/14, C07D471/04
[2014/11]
CPC:
C07D403/14 (EP,US); A61P35/00 (EP); A61P35/02 (EP);
A61P43/00 (EP); C07D403/06 (EP,US); C07D405/14 (EP,US);
C07D413/14 (EP,US); C07D417/14 (EP,US); C07D471/04 (EP,US) (-)
Former IPC [2012/36]A01N43/50, A61K31/415
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2012/36]
TitleGerman:BENZIMIDAZOLE ALS FETTSÄURE-SYNTHASE-HEMMER[2012/36]
English:BENZIMIDAZOLES AS FATTY ACID SYNTHASE INHIBITORS[2012/36]
French:BENZIMIDAZOLES UTILISÉS EN TANT QU'INHIBITEURS DE L'ACIDE GRAS SYNTHASE[2012/36]
Entry into regional phase18.05.2012National basic fee paid 
18.05.2012Search fee paid 
18.05.2012Designation fee(s) paid 
18.05.2012Examination fee paid 
Examination procedure18.05.2012Amendment by applicant (claims and/or description)
18.05.2012Examination requested  [2012/36]
09.09.2014Application deemed to be withdrawn, date of legal effect  [2015/22]
21.11.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2015/22]
Fees paidRenewal fee
05.10.2012Renewal fee patent year 03
07.10.2013Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.10.201405   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]  - HORIGUCHI A ET AL, "Pharmacological Inhibitor of Fatty Acid Synthase Suppresses Growth and Invasiveness of Renal Cancer Cells", JOURNAL OF UROLOGY, LIPPINCOTT WILLIAMS & WILKINS, BALTIMORE, MD, US, vol. 180, no. 2, doi:10.1016/J.JURO.2008.03.186, ISSN 0022-5347, (20080801), pages 729 - 736, (20080613), XP022825417 [A] 1-12 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.juro.2008.03.186
 [A]  - XUAN WANG ET AL, "The galloyl moiety of green tea catechins is the critical structural feature to inhibit fatty-acid synthase", BIOCHEMICAL PHARMACOLOGY, (20031101), vol. 66, no. 10, doi:10.1016/S0006-2952(03)00585-9, ISSN 0006-2952, pages 2039 - 2047, XP055099173 [A] 1-12 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0006-2952(03)00585-9
 [A]  - THUPARI ET AL, "Fatty Acid Synthase Inhibition in Human Breast Cancer Cells Leads to Malonyl-CoA-Induced Inhibition of Fatty Acid Oxidation and Cytotoxicity", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, (20010713), vol. 285, no. 2, doi:10.1006/BBRC.2001.5146, ISSN 0006-291X, pages 217 - 223, XP005100767 [A] 1-12 * the whole document *

DOI:   http://dx.doi.org/10.1006/bbrc.2001.5146
 [A]  - ZHANG S Y ET AL, "Low concentration of condensed tannins from catechu significantly inhibits fatty acid synthase and growth of MCF-7 cells", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 371, no. 4, doi:10.1016/J.BBRC.2008.04.062, ISSN 0006-291X, (20080711), pages 654 - 658, (20080422), XP022688438 [A] 1-12 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.bbrc.2008.04.062
 [A]  - YU F ET AL, "Inhibition of Coix seed extract on fatty acid synthase, a novel target for anticancer activity", JOURNAL OF ETHNOPHARMACOLOGY, ELSEVIER IRELAND LTD, IE, vol. 119, no. 2, doi:10.1016/J.JEP.2008.07.015, ISSN 0378-8741, (20080926), pages 252 - 258, (20080723), XP025399344 [A] 1-12 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.jep.2008.07.015
 [A]  - WENG ET AL, "Theanaphthoquinone inhibits fatty acid synthase expression in EGF-stimulated human breast cancer cells via the regulation of EGFR/ErbB-2 signaling", TOXICOLOGY AND APPLIED PHARMACOLOGY, ACADEMIC PRESS, AMSTERDAM, NL, (20070201), vol. 218, no. 2, doi:10.1016/J.TAAP.2006.10.021, ISSN 0041-008X, pages 107 - 118, XP005737697 [A] 1-12 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.taap.2006.10.021
International search[X]US2007004713  (BARLAAM BERNARD [FR], et al);
 [Y]US2007043043  (CHEN DIZHONG [SG], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.